Stay updated on Vyvanse Adolescent Safety Clinical Trial
Sign up to get notified when there's something new on the Vyvanse Adolescent Safety Clinical Trial page.

Latest updates to the Vyvanse Adolescent Safety Clinical Trial page
- Check4 days agoChange DetectedA new site revision tag v3.4.3 is displayed, replacing the previous v3.4.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded site Revision: v3.4.2. Removed the funding-status notice about government funding lapses and the prior Revision: v3.4.1 banner.SummaryDifference0.3%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding and ongoing operating status is added (with references to cc.nih.gov and opm.gov). The site revision is updated to v3.4.1, replacing the previous v3.4.0 revision notice.SummaryDifference0.3%

- Check48 days agoChange DetectedThe changes are minor UI and metadata label updates on the study record page, including a glossary toggle (Show glossary), a new 'Last Update Submitted that Met QC Criteria' label, capitalization adjustments (No FEAR Act Data), and a new 'Revision: v3.4.0' badge. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor backend revision with no impact on study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations are now listed by state (Arkansas, California, Florida, etc.) with a new Revision: v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference2%

Stay in the know with updates to Vyvanse Adolescent Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vyvanse Adolescent Safety Clinical Trial page.